test

The chart shows the growth of an initial investment of $10,000 in test, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since May 31, 2021, test's average daily return is +0.04%, while the average monthly return is +0.85%. At this rate, your investment would double in approximately 6.8 years.

Historically, 63% of months were positive and 37% were negative. The best month was Nov 2023 with a return of +9.4%, while the worst month was Sep 2022 at -9.5%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 3 months.

On a daily basis, test closed higher 54% of trading days. The best single day was Apr 9, 2025 with a return of +8.0%, while the worst single day was Apr 4, 2025 at -5.7%.

test has an annualized alpha of 0.54%, beta of 0.86, and R² of 0.83 versus S&P 500 Index. Calculated based on daily prices since May 31, 2021.

• This portfolio participated in 89.32% of S&P 500 Index downside but only 85.92% of its upside — more exposed to losses than it benefited from rallies.
• With beta of 0.86 and R² of 0.83, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

test has an expense ratio of 0.14%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

test ranks 80 for risk / return — in the top 80% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

test Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

• 1-Year: 1.68
• All Time: 0.62

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.00 to 1.68, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of test compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

test provided a 1.69% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the test. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the test was 24.53%, occurring on Oct 12, 2022. Recovery took 325 trading sessions.

The current test drawdown is 5.53%.

The chart below shows the rolling one-month volatility.